Dr. Anthony Fauci on Sunday told Margaret Brennan on “Face the Nation” that scientific evidence does not support President Donald Trump’s repeated claim that hydroxychloroquine can prevent the coronavirus. (Photo: Alliance for Health Policy/Flickr/cc)
The nation’s top expert on infectious diseases was forced once again on Sunday to negate President Donald Trump’s latest claim that an anti-malaria drug can treat coronavirus, which the president made at his Saturday evening press conference.
On CBS’s “Face the Nation,” National Institute of Allergy and Infectious Diseases (NIAID) director Dr. Anthony Fauci told host Margaret Brennan that “in terms of science, I don’t think we could definitively say it works,” regarding the use of hydroxychloroquine for the virus. Continue reading →
However, a study just published in a French medical journal provides new evidence that hydroxychloroquine does not appear to help the immune system clear the coronavirus from the body. The study comes on the heels of two others – one in France and one in China – that reported some benefits in the combination of hydroxychloroquine and azithromycin for COVID-19 patients who didn’t have severe symptoms of the virus. Continue reading →
As healthcare providers across the U.S. desperately attempt to treat a rapidly growing number of patients with the coronavirus, a pharmaceutical company with ties to the Trump administration has been granted exclusive status for a drug it is developing to treat the illness—a potential windfall for the company that could put the medication out of reach for many Americans.
As The Interceptreported Monday, the Food and Drug Administration granted Gilead Sciences “orphan” drug status for remdesivir, one of several drugs being tested as potential treatments for the coronavirus, officially known as COVID-19. The designation is generally reserved for drugs that treat rare illnesses affecting fewer than 200,000 Americans—but companies can be eligible if the designation, as in this case of a rapidly spreading virus, is made before a disease spreads beyond that limit. Continue reading →
The Affordable Care Act remains on life support after a panel of federal judges ruled on Dec. 18, 2019 that the law’s individual mandate requiring people to buy health insurance is unconstitutional.
The decision hobbles the law in ways that are hard to predict politically, particularly in the upcoming election year. It also raises questions for the 20 million people who gained coverage in the marketplaces and all Americans who gained protections through the ACA. Continue reading →
Corporations’ quest for profits is what “is driving up drug prices and nothing more.”
That’s according to Dennis Bourdette, M.D., chair of neurology in the Oregon Health and Science University (OHSU) School of Medicine, who co-authored a study published Monday that sought to find out companies’ rationale for the escalating prices on medications for patients with multiple sclerosis. Continue reading →
U.K. Labour Leader Jeremy Corbyn holds redacted copies of the Department for International Trade’s U.K.-U.S. Trade and Investment Working Group report following a speech about the National Health Service in Westminster, London. Photo: Devutopia/Twitter
U.K. Labour leader Jeremy Corbyn on Wednesday unveiled over 450 pages of leaked documents that he said expose British Prime Minister Boris Johnson’s effort to open up the National Health Service to corporate exploitation in trade negotiations with U.S. President Donald Trump.
During a press conference, Corbyn said the Trump administration’s negotiators are “demanding” that the NHS be put “on the table” in talks over a possible post-Brexit trade pact between the U.S. and U.K. Continue reading →
Samir Saran, President, Observer Research Foundation (ORF), India, Alice Bunn, Director, International, UK Space Agency, United Kingdom, Frederick Kempe, President and Chief Executive Officer, Atlantic Council, USA speaking during the Session “Future Frontiers of Technology Control ” in “Situation Room” at the Annual Meeting 2019 of the World Economic Forum in Davos, January 22, 2018. Photo: Greg Beadle – World Economic Forum/flickr/CC
Over 200 civil society groups this week voiced their firm opposition to a recently-inked agreement between the United Nations and World Economic Forum that stands to further entrench transnational corporations and their interests in global governance.
“It moves the world dangerously towards a privatized and undemocratic global governance,” said Gonzalo Berrón of Transnational Institute. Continue reading →
“It’s time for the AMA to join the majority of physicians who support improved Medicare for All.”
-By Jake Johnson, staff writer for Common Dreams. Published 6-7-2019
Medicare for All Rally, Los Angeles – Feb 2017. Photo: Molly Adams/flickr
Accusing the American Medical Association of putting “profits ahead of patient care” by joining the corporate fight against Medicare for All, a coalition of physicians, nurses, and allies plans to march on the organization’s annual meeting on Saturday to demand an end to its longstanding opposition to single-payer.
The AMA is America’s largest association of physicians, one of the largest lobbying organizations in the U.S., and a founding member of the Partnership for America’s Health Care Future, a coalition formed by insurance and pharmaceutical interests to combat Medicare for All. Continue reading →
Pfizer World Headquarters – New York City. Photo: Norbert Nagel/CC
A far-reaching lawsuit filed Friday by the attorneys general of more than 40 states accused some of the nation’s largest generic drug manufacturers of conspiring to inflate prices, in some cases by over 1,000 percent.
“We have hard evidence that shows the generic drug industry perpetrated a multi-billion dollar fraud on the American people,” Connecticut Attorney General William Tong, whose state led the probe into the companies’ practices, said in a statement. Continue reading →
Nurses use Band-Aids to attach GoFundMe pages to the headquarters of Pharmaceutical Research and Manufacturers of America in Washington, D.C. (Photo: National Nurses United/Twitter)
Hundreds of nurses and their allies from across the country rallied Monday outside the headquarters of the pharmaceutical industry’s top lobbying group and plastered the GoFundMe pages of Americans “suffering in an immoral healthcare system” to the building’s walls and windows.